I get what you're saying. But we're all oversimplifying it dramatically.
CF33 does work. There's plenty of data to support that already. How well? That's what they're working on. Let's achieve OBD first.
Just imagine if it could be used as a 1st line? Pre-chemo. Without decimating the patient's immune system first. Then you can combine with any CD19 targeting therapy. Of which there are many.
We've only just begun. We're so impatient. The wait will be worth it.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
27.0¢ |
Change
-0.010(3.57%) |
Mkt cap ! $77.89M | |||
| Open | High | Low | Value | Volume |
| 28.0¢ | 28.0¢ | 26.3¢ | $1.990M | 7.367M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 20000 | 27.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 27.5¢ | 209631 | 9 |
View Market Depth
| Last trade - 16.10pm 25/07/2025 (20 minute delay) ? |
| IMU (ASX) Chart |